Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001026989 | SCV001189475 | pathogenic | Hereditary cancer-predisposing syndrome | 2019-01-31 | criteria provided, single submitter | clinical testing | The c.795_801+1delAAAAAAGG pathogenic mutation results from the deletion of 8 nucleotides from positions c.795 to c.801+1 between coding exon 7 and intron 7 of the PTEN gene. This alteration was confirmed to be a de novo occurrence in a proband with features of PTEN hamartoma tumor syndrome (PHTS) (Ambry internal data). Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation. |